
Kimberly Chong
Examiner (ID: 8669, Phone: (571)272-3111 , Office: P/1674 )
| Most Active Art Unit | 1635 |
| Art Unit(s) | 1636, 1635, 1674 |
| Total Applications | 2007 |
| Issued Applications | 1153 |
| Pending Applications | 209 |
| Abandoned Applications | 674 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6632017
[patent_doc_number] => 20100311814
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-09
[patent_title] => 'MODULATION OF STAT5 EXPRESSION'
[patent_app_type] => utility
[patent_app_number] => 12/710232
[patent_app_country] => US
[patent_app_date] => 2010-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24476
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20100311814.pdf
[firstpage_image] =>[orig_patent_app_number] => 12710232
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/710232 | Modulation of stat5 expression | Feb 21, 2010 | Issued |
Array
(
[id] => 10033741
[patent_doc_number] => 09075053
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-07-07
[patent_title] => 'Target substance detection method using aptamer'
[patent_app_type] => utility
[patent_app_number] => 13/201764
[patent_app_country] => US
[patent_app_date] => 2010-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 8783
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13201764
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/201764 | Target substance detection method using aptamer | Feb 15, 2010 | Issued |
Array
(
[id] => 10098008
[patent_doc_number] => 09134315
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-09-15
[patent_title] => 'Use of the lactosylceramide synthase isoform B1,4GalT-V as a biomarker for cancer'
[patent_app_type] => utility
[patent_app_number] => 13/578657
[patent_app_country] => US
[patent_app_date] => 2010-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 11
[patent_no_of_words] => 25467
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13578657
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/578657 | Use of the lactosylceramide synthase isoform B1,4GalT-V as a biomarker for cancer | Feb 11, 2010 | Issued |
Array
(
[id] => 8241023
[patent_doc_number] => 20120149763
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-14
[patent_title] => 'PHARMACEUTICAL COMPOSITION FOR TREATING ADVERSE REACTIONS DUE TO ADMINISTRATION OF SPIEGELMERS'
[patent_app_type] => utility
[patent_app_number] => 13/148142
[patent_app_country] => US
[patent_app_date] => 2010-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 3928
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13148142
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/148142 | PHARMACEUTICAL COMPOSITION FOR TREATING ADVERSE REACTIONS DUE TO ADMINISTRATION OF SPIEGELMERS | Feb 7, 2010 | Abandoned |
Array
(
[id] => 6328468
[patent_doc_number] => 20100197773
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-05
[patent_title] => 'COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF PTP1B GENES'
[patent_app_type] => utility
[patent_app_number] => 12/696100
[patent_app_country] => US
[patent_app_date] => 2010-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 43
[patent_no_of_words] => 16731
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20100197773.pdf
[firstpage_image] =>[orig_patent_app_number] => 12696100
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/696100 | COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF PTP1B GENES | Jan 28, 2010 | Abandoned |
Array
(
[id] => 7776570
[patent_doc_number] => 20120040004
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-16
[patent_title] => 'TREATMENT OF RADIATION-INDUCED FIBROSIS'
[patent_app_type] => utility
[patent_app_number] => 13/146498
[patent_app_country] => US
[patent_app_date] => 2010-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7588
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20120040004.pdf
[firstpage_image] =>[orig_patent_app_number] => 13146498
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/146498 | TREATMENT OF RADIATION-INDUCED FIBROSIS | Jan 27, 2010 | Abandoned |
Array
(
[id] => 7669518
[patent_doc_number] => 20110318787
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-29
[patent_title] => 'MEANS AND METHODS FOR MODULATING NOTCH3 PROTEIN EXPRESSION AND/OR THE CODING REGION OF NOTCH3; COMPOSITIONS AND USE THEREOF IN THE TREATMENT OF CADASIL'
[patent_app_type] => utility
[patent_app_number] => 13/145873
[patent_app_country] => US
[patent_app_date] => 2010-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6496
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13145873
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/145873 | Means and methods for modulating NOTCH3 protein expression and/or the coding region of NOTCH3; compositions and use thereof in the treatment of CADASIL | Jan 25, 2010 | Issued |
Array
(
[id] => 8270360
[patent_doc_number] => 08211866
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-07-03
[patent_title] => 'Methods and compositions for treating HIV infection'
[patent_app_type] => utility
[patent_app_number] => 12/687255
[patent_app_country] => US
[patent_app_date] => 2010-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5583
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12687255
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/687255 | Methods and compositions for treating HIV infection | Jan 13, 2010 | Issued |
Array
(
[id] => 10090458
[patent_doc_number] => 09127273
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-09-08
[patent_title] => 'UNC-45A splice variants based cancer diagnostics and therapeutics'
[patent_app_type] => utility
[patent_app_number] => 13/144476
[patent_app_country] => US
[patent_app_date] => 2010-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13352
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13144476
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/144476 | UNC-45A splice variants based cancer diagnostics and therapeutics | Jan 11, 2010 | Issued |
Array
(
[id] => 9965006
[patent_doc_number] => 09012622
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-04-21
[patent_title] => 'Compositions and methods using siRNA molecules and siRNA cocktails for the treatment of breast cancer'
[patent_app_type] => utility
[patent_app_number] => 13/141122
[patent_app_country] => US
[patent_app_date] => 2009-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 14945
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13141122
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/141122 | Compositions and methods using siRNA molecules and siRNA cocktails for the treatment of breast cancer | Dec 30, 2009 | Issued |
Array
(
[id] => 8618266
[patent_doc_number] => 20130023578
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-24
[patent_title] => 'siRNA for inhibition of c-Met expression and anticancer composition containing the same'
[patent_app_type] => utility
[patent_app_number] => 13/519936
[patent_app_country] => US
[patent_app_date] => 2009-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11156
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13519936
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/519936 | siRNA for inhibition of c-Met expression and anticancer composition containing the same | Dec 27, 2009 | Abandoned |
Array
(
[id] => 6627828
[patent_doc_number] => 20100172976
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-08
[patent_title] => 'METHODS AND COMPOSITIONS FOR INHIBITING THE FUNCTION OF POLYNUCLEOTIDE SEQUENCES'
[patent_app_type] => utility
[patent_app_number] => 12/642367
[patent_app_country] => US
[patent_app_date] => 2009-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 16687
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0172/20100172976.pdf
[firstpage_image] =>[orig_patent_app_number] => 12642367
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/642367 | METHODS AND COMPOSITIONS FOR INHIBITING THE FUNCTION OF POLYNUCLEOTIDE SEQUENCES | Dec 17, 2009 | Abandoned |
Array
(
[id] => 6592909
[patent_doc_number] => 20100130592
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-27
[patent_title] => 'RNA Interference Mediated Inhibition of GRB2 Associated Binding Protein (GAB2) Gene Expression Using Short Interfering Nucleic Acid (siNA)'
[patent_app_type] => utility
[patent_app_number] => 12/640668
[patent_app_country] => US
[patent_app_date] => 2009-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 65343
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20100130592.pdf
[firstpage_image] =>[orig_patent_app_number] => 12640668
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/640668 | RNA interference mediated inhibition of GRB2 associated binding protein (GAB2) gene expression using short interfering nucleic acid (siNA) | Dec 16, 2009 | Issued |
Array
(
[id] => 6616927
[patent_doc_number] => 20100099743
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-22
[patent_title] => 'RNA INTERFERENCE MEDIATED INHIBITION OF CHECKPOINT KINASE-1 (CHK-1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)'
[patent_app_type] => utility
[patent_app_number] => 12/640489
[patent_app_country] => US
[patent_app_date] => 2009-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 60695
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20100099743.pdf
[firstpage_image] =>[orig_patent_app_number] => 12640489
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/640489 | RNA interference mediated inhibition of checkpoint kinase-1 (CHK-1) gene expression using short interfering nucleic acid (siNA) | Dec 16, 2009 | Issued |
Array
(
[id] => 6426606
[patent_doc_number] => 20100168208
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-01
[patent_title] => 'RNA INTERFERENCE MEDIATED TREATMENT OF ALZHEIMER\'S DISEASE USING SHORT INTERFERING NUCLEIC ACID (siNA)'
[patent_app_type] => utility
[patent_app_number] => 12/640411
[patent_app_country] => US
[patent_app_date] => 2009-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 52878
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0168/20100168208.pdf
[firstpage_image] =>[orig_patent_app_number] => 12640411
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/640411 | RNA interference mediated treatment of alzheimer's disease using short interfering nucleic acid (siNA) | Dec 16, 2009 | Issued |
Array
(
[id] => 8386174
[patent_doc_number] => 08263570
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-09-11
[patent_title] => 'Treating picornavirus infection by targeting MicroRNA miR-141'
[patent_app_type] => utility
[patent_app_number] => 12/638737
[patent_app_country] => US
[patent_app_date] => 2009-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7487
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12638737
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/638737 | Treating picornavirus infection by targeting MicroRNA miR-141 | Dec 14, 2009 | Issued |
Array
(
[id] => 8063389
[patent_doc_number] => 20110245325
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-06
[patent_title] => 'PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CANCER AND ASTHMA'
[patent_app_type] => utility
[patent_app_number] => 13/139280
[patent_app_country] => US
[patent_app_date] => 2009-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13011
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0245/20110245325.pdf
[firstpage_image] =>[orig_patent_app_number] => 13139280
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/139280 | Pharmaceutical composition for treatment of cancer and asthma | Dec 13, 2009 | Issued |
Array
(
[id] => 6080281
[patent_doc_number] => 20110142913
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-16
[patent_title] => 'COMPOSITION AND METHOD FOR TREATING ATHEROSCLEROSIS, METHOD FOR DETERMINING IF A SUBJECT HAS ATHEROSCLEROSIS AND METHOD OF SCREENING AN ANTI-ATHEROSCLEROTIC DRUG'
[patent_app_type] => utility
[patent_app_number] => 12/635178
[patent_app_country] => US
[patent_app_date] => 2009-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5476
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20110142913.pdf
[firstpage_image] =>[orig_patent_app_number] => 12635178
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/635178 | Composition and method for treating atherosclerosis, method for determining if a subject has atherosclerosis and method of screening an anti-atherosclerotic drug | Dec 9, 2009 | Issued |
Array
(
[id] => 7808087
[patent_doc_number] => 20120059041
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-08
[patent_title] => 'Methods for Extending Lifespan in Subject'
[patent_app_type] => utility
[patent_app_number] => 12/633640
[patent_app_country] => US
[patent_app_date] => 2009-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 2300
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20120059041.pdf
[firstpage_image] =>[orig_patent_app_number] => 12633640
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/633640 | Methods for Extending Lifespan in Subject | Dec 7, 2009 | Abandoned |
Array
(
[id] => 6323045
[patent_doc_number] => 20100113760
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-06
[patent_title] => 'siRNA targeting myeloid differentiation primary response gene (88) (MYD88)'
[patent_app_type] => utility
[patent_app_number] => 12/653120
[patent_app_country] => US
[patent_app_date] => 2009-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 44
[patent_no_of_words] => 34621
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20100113760.pdf
[firstpage_image] =>[orig_patent_app_number] => 12653120
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/653120 | SiRNA targeting myeloid differentiation primary response gene (88) (MYD88) | Dec 7, 2009 | Issued |